SMN1 and central nervous system cancer: Explanations for the discrepant in vivo and in vitro results may comprise hypoxic tumor cores in vivo, a well-known contributor to increased radioresistance45,46, or reciprocal interactions of SMA-560 glioma cells with the tumor microenvironment and stroma cells47,48.